Gonadotrophins - Filled-by-mass versus filled-by-bioassay

Reproductive BioMedicine Online

Volumn 10, Issue SUPPL. 3, 2005, Pages 11-17

  Hugues, Jean Noel ^a   Durnerin, I Cédrin ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Filled by mass process; IVF; Ovulation induction; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN AGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ANOVULATION; ARTICLE; BIOASSAY; CALIBRATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SAFETY; DRUG SYNTHESIS; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GEL PERMEATION CHROMATOGRAPHY; HUMAN; NONHUMAN; OVULATION INDUCTION; PATIENT MONITORING; PREGNANCY RATE;

EID: 22244441486     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(11)60385-4     Document Type: Article

References (14)

1. Balasch J, Fabregues F, Penarrubia J et al. 2004 Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass. Reproductive BioMedicine Online 8, 403-413.
2. Bassett RM, Driebergen R 2004 Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH. Reproductive BioMedicine Online 10, 169-177.
3. Carriza C, Alam V, Yeko T et al. 2003 Gonal F filled-by-mass in ovulation induction. Human Reproduction 18 (Suppl. 1) 0.117.
4. Driebergen R, Baer G 2003 Quantification of follicle stimulating hormone (follitropin alfa): is in-vivo bio-assay still relevant in the recombinant age? Current Medical Research and Opinion 19, 41-46.
5. Hugues JN, Barlow D, Rozenwaks Z et al. 2003 Improvement in the consistency of response to ovarian stimulation with recombinant human follicle stimulating hormone resulting from a new method for calibrating the therapeutic preparation. Reproductive BioMedicine Online 6, 185-190.
6. Lass A, McVeigh E on behalf of the UK Gonal-f FbM PMS Group 2004 Routine use of rFSH follitropin alfa filled-by-mass for follicular development for IVF: a large multicenter observational study in the UK. Reproductive BioMedicine Online 9, 604-610.
7. Loumaye E, Dreano M, Glazka A et al. 1998 Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility. Human Reproduction Update 4, 862-881.
8. Ludwig M, Bilger W 2004 Post marketing analysis of the routine use of a new preparation of follitropin alfa in 68 German In Vitro Fertilization centers. Fifth World Congress on Controversies in Obstetrics, Gynaecology and Infertility, Las Vegas, USA, p. 31.
9. Mulders AM, Laven JSE, Eijkemans JC et al. 2003 Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Human Reproduction Update 9, 429-449.
10. Penzias A 2004 Improving results with assited reproductive technologies: individualized patient-tailored strategies for ovulation induction. Reproductive BioMedicine Online 9, 43-46.
11. Popovic-Todorovic B, Loft A et al. 2003 A prospective study of predictive factors of ovarian response in standard IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Human Reproduction 18, 781-787.
12. Steelman SL, Pohley FM 1953 Assay of follicle stimulating hormone based on the augmentation with human chorionic gonadotrophin. Endocrinology 53, 604-616.
13. Stone BA, Quinn K, Quinn P et al. 1989 Responses of patients to different lots of human menopausal gonadotropins during controlled ovarian hyperstimulation. Fertility and Sterility 52, 745-752.
14. Tur R, Barri PN, Coroleu B et al. 2001 Risk factors for high order multiple implantation after ovarian stimulation with gonadotrophins: evidence from a large series of 1878 consecutive pregnancies from a single center. Human Reproduction 16, 326-332.